ARMC
AVNS icon

American Research & Management Company’s Avanos Medical AVNS Stock Holding History

American Research & Management Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25
Closed -$1K – 397
2021
Q4 		$1K Buy
+25
New +$808 ﹤0.01% 371

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Research & Management Company's AVNS Position: Q1 2022 in Review

American Research & Management Company sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 25 shares — an estimated $1K sold.

American Research & Management Company first reported a position in AVNS in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

  • American Research & Management Company reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
  • American Research & Management Company sold 25 Avanos Medical shares in Q1 2022, an estimated $1K.
  • American Research & Management Company first reported a position in Avanos Medical in Q4 2021 and held it in 1 quarter.
  • American Research & Management Company's Avanos Medical position peaked at $1K in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on American Research & Management Company's 13F filing for Q1 2022, filed 21 Apr 2022.